Literature DB >> 7790883

Distribution of calretinin, calbindin D28k, and parvalbumin in subcellular fractions of rat cerebellum: effects of calcium.

L Winsky1, J Kuźnicki.   

Abstract

The distribution of calretinin, calbindin D28k, and parvalbumin was examined in subcellular fractions prepared from rat cerebellum and analyzed by immunoblot. Calretinin was also quantified by radioimmunoassay. As expected, all three soluble, EF-hand calcium-binding proteins were predominantly localized in the cytosolic fraction. Calretinin and calbindin D28k were also detected in membrane fractions. Calretinin was more abundant in synaptic membrane than in microsomal fractions. The cerebellar microsomal fraction contained the greatest concentration of membrane-associated calbindin D28k. The association of calretinin and calbindin D28k with membrane fractions was decreased in samples prepared or incubated in low calcium. Quantification of calretinin in subcellular fractions of rat cerebellum revealed a greater amount of calretinin in cytosolic fractions prepared or incubated in low calcium and reduced amounts of calretinin in all membrane fractions incubated in low calcium with the exception of the mitochondrial fraction. These results imply that calretinin and calbindin D28k might have physiological target molecules that are associated with, or are components of, brain membranes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790883     DOI: 10.1046/j.1471-4159.1995.65010381.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  Development and dissipation of Ca(2+) gradients in adrenal chromaffin cells.

Authors:  F D Marengo; J R Monck
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

Review 2.  Models of calcium dynamics in cerebellar granule cells.

Authors:  Elena È Saftenku
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

3.  Calbindin D28k targets myo-inositol monophosphatase in spines and dendrites of cerebellar Purkinje neurons.

Authors:  Hartmut Schmidt; Beat Schwaller; Jens Eilers
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

4.  Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene.

Authors:  M S Airaksinen; J Eilers; O Garaschuk; H Thoenen; A Konnerth; M Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

5.  Surviving granule cells of the sclerotic human hippocampus have reduced Ca(2+) influx because of a loss of calbindin-D(28k) in temporal lobe epilepsy.

Authors:  U V Nägerl; I Mody; M Jeub; A A Lie; C E Elger; H Beck
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

Review 6.  The molecular identity of the mitochondrial Ca2+ sequestration system.

Authors:  Anatoly A Starkov
Journal:  FEBS J       Date:  2010-07-26       Impact factor: 5.542

7.  Calretinin regulates Ca2+-dependent inactivation and facilitation of Ca(v)2.1 Ca2+ channels through a direct interaction with the α12.1 subunit.

Authors:  Carl J Christel; Raphael Schaer; Shiyi Wang; Thomas Henzi; Lisa Kreiner; Detlev Grabs; Beat Schwaller; Amy Lee
Journal:  J Biol Chem       Date:  2012-10-02       Impact factor: 5.157

Review 8.  Homeostatic compensation maintains Ca2+ signaling functions in Purkinje neurons in the leaner mutant mouse.

Authors:  David Murchison; Leonard S Dove; Louise C Abbott; William H Griffith
Journal:  Cerebellum       Date:  2002-04       Impact factor: 3.847

Review 9.  'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice.

Authors:  Beat Schwaller; Michael Meyer; Serge Schiffmann
Journal:  Cerebellum       Date:  2002-12       Impact factor: 3.847

10.  Spatiotemporal patterning of IP3-mediated Ca2+ signals in Xenopus oocytes by Ca2+-binding proteins.

Authors:  Sheila L Dargan; Beat Schwaller; Ian Parker
Journal:  J Physiol       Date:  2004-01-30       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.